• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一大群人中使用MDRD方程和CKD-EPI方程估算肾小球滤过率(eGFR)用于慢性肾脏病(CKD)筛查的比较。

Comparison of estimated glomerular filtration rate (eGFR) using the MDRD and CKD-EPI equations for CKD screening in a large population.

作者信息

Giavarina D, Cruz D N, Soffiati G, Ronco C

机构信息

Dipartimento di Patologia Clinica, Vicenza, Italy.

出版信息

Clin Nephrol. 2010 Nov;74(5):358-63. doi: 10.5414/cnp74358.

DOI:10.5414/cnp74358
PMID:20979944
Abstract

BACKGROUND/AIMS: recently, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) proposed a new equation for estimating glomerular filtration rate (eGFR), which could potentially replace the Modified Diet for Renal Disease Study (MDRD) equation in routine clinical use. Our aim was to evaluate the correlation between them and to compare the prevalence of each CKD stage using these two equations.

METHODS

we measured serum creatinine in 38,188 consecutive patients and calculated eGFR using the CKD-EPI and MDRD equations. We also compared the distribution of CKD stages for both equations.

RESULTS

there was very good correlation between eGFR estimated by CKD-EPI and MDRD at values < 60 ml/min × 1.73 m2, but not at higher values. Estimated prevalence of CKD (eGFR < 60 ml/min × 1.73 m2) was 5.9% with CKD-EPI and 7.5% with MDRD. Furthermore, the prevalence of CKD Stage 2 was lower with CKD-EPI (33.8% vs. 49.1%. with MDRD).

CONCLUSION

the use of the CKD-EPI equation results in a lower estimated prevalence of CKD, compared to the MDRD equation. This may have important implications for public health and clinical practice, as well as for future modification of guidelines for laboratories.

摘要

背景/目的:最近,慢性肾脏病流行病学协作组(CKD-EPI)提出了一种新的估算肾小球滤过率(eGFR)的方程,该方程可能会在常规临床应用中取代肾病研究改良饮食(MDRD)方程。我们的目的是评估它们之间的相关性,并使用这两个方程比较每个慢性肾脏病阶段的患病率。

方法

我们测量了38188例连续患者的血清肌酐,并使用CKD-EPI和MDRD方程计算eGFR。我们还比较了两个方程的慢性肾脏病阶段分布情况。

结果

当eGFR值<60 ml/min×1.73 m2时,CKD-EPI和MDRD估算的eGFR之间具有很好的相关性,但在较高值时则不然。CKD-EPI估算的慢性肾脏病(eGFR<60 ml/min×1.73 m2)患病率为5.9%,MDRD为7.5%。此外,CKD-EPI估算的2期慢性肾脏病患病率较低(分别为33.8%和49.1%,MDRD)。

结论

与MDRD方程相比,使用CKD-EPI方程估算的慢性肾脏病患病率较低。这可能对公共卫生和临床实践以及实验室指南的未来修订具有重要意义。

相似文献

1
Comparison of estimated glomerular filtration rate (eGFR) using the MDRD and CKD-EPI equations for CKD screening in a large population.在一大群人中使用MDRD方程和CKD-EPI方程估算肾小球滤过率(eGFR)用于慢性肾脏病(CKD)筛查的比较。
Clin Nephrol. 2010 Nov;74(5):358-63. doi: 10.5414/cnp74358.
2
Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.比较使用 CKD-EPI 和 MDRD 研究 GFR 估算方程的 CKD 患病率和死亡率风险:AusDiab(澳大利亚糖尿病、肥胖和生活方式)研究。
Am J Kidney Dis. 2010 Apr;55(4):660-70. doi: 10.1053/j.ajkd.2009.12.011.
3
Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations.不同临床表现患者中,MDRD 和 CKD-EPI 方程估计肾小球滤过率的相对性能。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1963-72. doi: 10.2215/CJN.02300311. Epub 2011 Jul 7.
4
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?慢性肾脏病流行病学协作组胱抑素 C(CKD-EPI-CysC)方程对有症状多发性骨髓瘤初诊患者的总生存具有独立的预后价值;是否到了从 MDRD 方程转变为 CKD-EPI-CysC 方程的时候?
Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17.
5
Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.验证慢性肾脏病流行病学合作组(CKD-EPI)方程在晚期慢性肾衰竭中的应用。
Nefrologia. 2011;31(6):677-82. doi: 10.3265/Nefrologia.pre2011.Sep.11014.
6
Comparison of the MDRD and the CKD-EPI equations to estimate the glomerular filtration rate in the general population.比较 MDRD 和 CKD-EPI 方程在普通人群中估算肾小球滤过率。
Med Clin (Barc). 2010 May 15;134(14):617-23. doi: 10.1016/j.medcli.2009.07.055. Epub 2010 Mar 11.
7
[Assessment of the new CKD-EPI equation to estimate the glomerular filtration rate].[评估用于估算肾小球滤过率的新型CKD-EPI方程]
Nefrologia. 2010;30(2):185-94. doi: 10.3265/Nefrologia.pre2009.Dic.5838. Epub 2009 Dec 14.
8
Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes.比较 MDRD、CKD-EPI 和 Cockcroft-Gault 方程与大型糖尿病队列中肾小球滤过率的关系。
J Diabetes Complications. 2017 Sep;31(9):1376-1383. doi: 10.1016/j.jdiacomp.2017.06.016. Epub 2017 Jul 5.
9
Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry.中国 MDRD 研究和 CKD-EPI 肌酐方程的改良版评估肾小球滤过率与卒中后结局相关性的比较:来自中国国家卒中登记研究的结果。
Am J Kidney Dis. 2014 Jan;63(1):59-67. doi: 10.1053/j.ajkd.2013.08.008. Epub 2013 Oct 4.
10
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.新的慢性肾脏病流行病学合作(CKD-EPI)方程与 MDRD 研究方程在估计肾小球滤过率方面的风险意义比较:社区动脉粥样硬化风险研究(ARIC)。
Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009.12.016. Epub 2010 Feb 26.

引用本文的文献

1
A retrospective analysis of antineutrophil cytoplasmic antibody-associated vasculitis aiming for an equation prediction end-stage renal disease.一项针对抗中性粒细胞胞浆抗体相关性血管炎的回顾性分析,旨在建立方程预测终末期肾病。
Clin Rheumatol. 2022 Mar;41(3):773-781. doi: 10.1007/s10067-021-05972-5. Epub 2021 Nov 8.
2
Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.心力衰竭患者的肾功能监测——最佳频率是多少?一篇综述。
Br J Clin Pharmacol. 2018 Jan;84(1):5-17. doi: 10.1111/bcp.13434. Epub 2017 Oct 22.
3
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.
全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.
4
The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study.在基层医疗环境中慢性肾脏病的流行情况:一项瑞士横断面研究。
PLoS One. 2013 Jul 3;8(7):e67848. doi: 10.1371/journal.pone.0067848. Print 2013.
5
The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines.应用新 KDIGO 指南,不同肾小球滤过率估计方程对东南亚队列中慢性肾脏病患病率和危险分层的影响。
BMC Nephrol. 2012 Jan 6;13:1. doi: 10.1186/1471-2369-13-1.